This may be attributed to a compensatory effect of increased pS6, supporting the existence of SMO-independent, non-canonical regulation of Hedgehog-Gli signaling by key oncogenic drivers, as demonstrated in various myeloid malignancies [43]. This evidence concerns the gene SMO and myeloid neoplasm.